(0.57%) 5 157.09 points
(0.29%) 38 787 points
(0.65%) 16 261 points
(0.84%) $78.77
(3.78%) $2.22
(1.13%) $2 334.60
(3.18%) $27.54
(0.70%) $972.10
(-0.15%) $0.927
(-0.53%) $10.82
(-0.28%) $0.795
(-0.05%) $91.41
3 days till quarter result
(bmo 2024-05-09)
Expected move: +/- 6.29%
-2.08% $ 27.76
@ $17.99
Emitido: 14 feb 2024 @ 15:07
Retorno: 54.31%
Señal anterior: feb 14 - 14:44
Señal anterior:
Retorno: 1.47 %
Live Chart Being Loaded With Signals
Cullinan Oncology Inc., a biopharmaceutical company, focuses on developing a pipeline of targeted oncology and immuno-oncology therapies for cancer patients in the United States...
Stats | |
---|---|
Volumen de hoy | 94 546.00 |
Volumen promedio | 694 375 |
Capitalización de mercado | 1.20B |
EPS | $0 ( 2024-03-14 ) |
Próxima fecha de ganancias | ( $-0.900 ) 2024-05-09 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -7.52 |
ATR14 | $0.108 (0.39%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-29 | Fenton Mary Kay | Buy | 200 000 | Stock Option (Right to Buy) |
2024-04-29 | Fenton Mary Kay | Buy | 0 | |
2024-03-29 | Nguyen Nate | Sell | 0 | Common Stock |
2024-03-29 | Nguyen Nate | Sell | 0 | Common Stock |
2024-03-29 | Nguyen Nate | Sell | 26 750 | Stock Option (Right to Buy) |
INSIDER POWER |
---|
-16.93 |
Last 98 transactions |
Buy: 2 707 515 | Sell: 6 664 307 |
Volumen Correlación
Cullinan Oncology, LLC Correlación
10 Correlaciones Más Positivas | |
---|---|
BNIXU | 0.96 |
SGEN | 0.914 |
ATVI | 0.879 |
STAY | 0.876 |
VLATU | 0.874 |
TIOAU | 0.872 |
FTIV | 0.871 |
RADI | 0.87 |
NTIC | 0.868 |
FOCS | 0.867 |
10 Correlaciones Más Negativas | |
---|---|
RMRM | -0.924 |
NMTR | -0.915 |
TLGT | -0.887 |
CETX | -0.882 |
EVOK | -0.875 |
GLBS | -0.874 |
SBAC | -0.872 |
IDBA | -0.871 |
BFI | -0.869 |
WINT | -0.869 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Cullinan Oncology, LLC Correlación - Moneda/Commodity
Cullinan Oncology, LLC Finanzas
Annual | 2023 |
Ingresos: | $0 |
Beneficio Bruto: | $-310 000 (0.00 %) |
EPS: | $-3.69 |
FY | 2023 |
Ingresos: | $0 |
Beneficio Bruto: | $-310 000 (0.00 %) |
EPS: | $-3.69 |
FY | 2022 |
Ingresos: | $0 |
Beneficio Bruto: | $-93 000.00 (0.00 %) |
EPS: | $2.46 |
FY | 2021 |
Ingresos: | $18 943.00 |
Beneficio Bruto: | $18 943.00 (100.00 %) |
EPS: | $-0.00157 |
Financial Reports:
No articles found.
Cullinan Oncology, LLC
Cullinan Oncology Inc., a biopharmaceutical company, focuses on developing a pipeline of targeted oncology and immuno-oncology therapies for cancer patients in the United States. The company's lead candidate is the CLN-081, an orally available small molecule that is in a Phase I/IIa dose escalation and expansion trial for treating patients with non-small cell lung cancer. Its preclinical products include CLN-049, a humanized bispecific antibody for the treatment of acute myeloid leukemia; CLN-619, a monoclonal antibody for the treatment of solid tumors; CLN-617, a fusion protein for the treatment of solid tumors; CLN-978, a T cell engaging antibody for B-cell malignancies; Opal, a bispecific fusion protein to block the PD-1 axis, and to activate the 4-IBB/CD137 pathway on T cells in tumors; and Jade, a cell therapy to target a novel senescence and cancer-related protein. The company has collaboration agreements with Cullinan Pearl Corp. to develop, manufacture, and commercialize CLN-081 and products containing CLN-081; and Adimab, LLC to discover and/or optimize antibodies. Cullinan Oncology, Inc. was incorporated in 2016 and is headquartered in Cambridge, Massachusetts.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico